418 related articles for article (PubMed ID: 29448998)
1. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis.
Flodrova P; Flodr P; Pika T; Vymetal J; Holub D; Dzubak P; Hajduch M; Scudla V
Pathology; 2018 Apr; 50(3):261-268. PubMed ID: 29448998
[TBL] [Abstract][Full Text] [Related]
2. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
[TBL] [Abstract][Full Text] [Related]
3. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
4. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis.
Hamer JP; Janssen S; van Rijswijk MH; Lie KI
Eur Heart J; 1992 May; 13(5):623-7. PubMed ID: 1618203
[TBL] [Abstract][Full Text] [Related]
5. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
6. Nonsecretory immunoglobulin-derived amyloidosis of the heart: diagnosis by immunohistochemistry of the endomyocardium.
Chau EM; Cheung SC; Chow SL; Fu KH
Clin Cardiol; 1997 May; 20(5):494-6. PubMed ID: 9134284
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of myocardial biopsy and immunohistochemistry to the prognostic evaluation of cardiac amyloidosis].
Van de Walle JP; Fourcade L; Panagides D; Harle JR; Pellissier JF; Touze JE; Bory M
Arch Mal Coeur Vaiss; 1994 Feb; 87(2):235-9. PubMed ID: 7802531
[TBL] [Abstract][Full Text] [Related]
8. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
9. Amyloidosis and cardiac involvement.
Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the diagnosis and management of cardiac amyloidosis.
Sher T; Gertz MA
Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
[TBL] [Abstract][Full Text] [Related]
11. Amyloid cardiomyopathy.
Karafiatova L; Pika T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
[TBL] [Abstract][Full Text] [Related]
13. Amyloid cardiomyopathy: a hidden heart failure cause that is often misdiagnosed.
Tung-Chen Y; Arnau MÁ
Acta Clin Belg; 2018 Dec; 73(6):460-461. PubMed ID: 29663861
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Care of Patients with Cardiac Amyloidosis.
Itzhaki Ben Zadok O; Kornowski R
Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
[TBL] [Abstract][Full Text] [Related]
15. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
Hofer JF; Wimmer G
Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
[TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.
Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Michalak E; Jakubowska E; Sobieszczańska-Małek M; Deptuch T; Walczak E; Wagner T; Walski M; Rózański J; Kiedrowski M; Lubiszewska B; Hoffman P; Rózyłło W
Kardiol Pol; 2005 Jul; 63(7):20-35. PubMed ID: 16136426
[TBL] [Abstract][Full Text] [Related]
17. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
18. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
[No Abstract] [Full Text] [Related]
19. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
